Afinitor (everolimus)

pCPA File Number: 20808
Negotiation Status:
Negotiations were not pursued
Indication(s):
Subependymal giant cell astrocytoma associated with tuberous sclerosis complex
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0376-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: